Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire

Blood

Volumn 107, Issue 6, 2006, Pages 2373-2383

  Meyer Olson, Dirk ^b   Brady, Kristen W ^b   Bartman, Melissa T ^b   O'Sullivan, Kristin M ^b   Simons, Brenna C ^b   Conrad, Joseph A ^b   Duncan, Coley B ^b   Lorey, Shelly ^b   Siddique, Atif ^b   Draenert, Rika ^b   Addo, Marylyn ^b   Altfeld, Marcus ^b   Rosenberg, Eric ^b   Allen, Todd M ^b   Walker, Bruce D ^b   Kalams, Spyros A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; NEF PROTEIN; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DYNAMICS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; LONGITUDINAL STUDY; MOLECULAR EVOLUTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRUS INFECTION;

EID: 33644774481     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-04-1636     Document Type: Article

References (53)

1. Meyer-Olson D, Shoukry NH, Brady KW, et al. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med. 2004;200:307-319.
2. Horwitz MS, Yanagi Y, Oldstone MB. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity. J Virol. 1994;68:352-357.
3. Kalams SA, Johnson RP, Dynan MJ, et al. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J Exp Med. 1996;183:1669-1679.
4. Cohen GB, Islam SA, Noble MS, et al. Clonotype tracking of TCR repertoires during chronic virus infections. Virology. 2002;304:474-484.
5. Yang OO, Sarkis PT, Ali A, et al. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med. 2003;197:1365-1375.
6. Douek DC, Betts MR, Brenchley JM, et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol. 2002;168:3099-3104.
7. + TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J Immunol. 2003;171:307-316.
8. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68:6103-6110.
9. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
10. + lymphocytes. Science. 1999;283:857-860
11. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature. 2000;407:523-526.
12. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001;193:169-180.
13. Allen TM, O'Connor DH, Jing P, et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature. 2000;407:386-390.
14. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998;279:2103-2106.
15. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol. 1996;50:825-854.
16. Gandhi RT, Walker BD. Immunologic control of HIV-1. Annu Rev Med. 2002;53:149-172.
17. Price DA, Goulder PJ, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A. 1997;94:1890-1895.
18. + T lymphocytes. Proc Natl Acad Sci U S A. 2000;97:3382-3387.
19. Dalod M, Dupuis M, Deschemin JC, et al. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J Clin Invest. 1999;104:1431-1439.
20. Brander C, Goulder PJ. Recent advantages in HIV-1 CTL epitope characterization: HIV molecular database. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM (http://www.hiv.lanl.gov); 1999.
21. Mason D. Some quantitative aspects of T-cell repertoire selection: the requirement for regulatory T cells. Immunol Rev. 2001;182:80-88.
22. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol. 1996;14:1-27.
23. Messaoudi I, Guevara Patino JA, Dyall R, LeMaoult J, Nikolich-Zugich J. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense. Science. 2002;298:1797-1800.
24. Buseyne F, Chaix ML, Rouzioux C, Blanche S, Riviere Y. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children. J Virol. 2001;75:4941-4946.
25. Buseyne F, Riviere Y. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes. Int Immunol. 2001;13:941-950.
26. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 1998;19:395-404.
27. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature. 1994;370:463-467.
28. Soudeyns H, Campi G, Rizzardi GP, et al. Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood. 2000;95:1743-1751.
29. Chen ZW, Kou ZC, Lekutis C, et al. T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med. 1995;182:21-31.
30. Wilson JD, Ogg GS, Allen RL, et al. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med. 1998;188:785-790.
31. + repertoire during antiviral therapy. Nat Med. 1998;4:215-221.
32. + T-cell expansions in patients with human immunodeficiency virus infection receiving highly active combination therapy. Blood. 2001;97:1787-1795.
33. + T cell clones during primary HIV infection. Proc Natl Acad Sci U S A. 1997;94:9848-9853.
34. Islam SA, Hay CM, Hartman KE, et al. Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression. J Virol. 2001;75:4907-4911.
35. Addo MM, Altfeld M, Rosenberg ES, et al. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci U S A. 2001;98:1781-1786.
36. Bunce M, Fanning GC, Welsh KI. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;45:81-90.
37. Altfeld MA, Trocha A, Eldridge RL, et al. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol. 2000;74:8541-8549.
38. Day CL, Shea AK, Altfeld MA, et al. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol. 2001;75:6279-6291.
39. Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94-96.
40. Meyer-Olson D, Brady KW, Blackard JT, et al. Analysis of the TCR beta variable gene repertoire in chimpanzees: identification of functional homologs to human pseudogenes. J Immunol. 2003;170:4161-4169.
41. + T-cell responses containing replication of the primary virus. Nature. 2002;420:434-439.
42. Ortiz GM, Wellons M, Brancato J, et al. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc Natl Acad Sci U S A. 2001;98:13288-13293.
43. Kalams SA, Goulder PJ, Shea AK, et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol. 1999;73:6721-6728.
44. + T lymphocytes with changes in viral load. The RESTIM and COMET Study Groups. J Immunol. 2000;165:1692-1704.
45. Price DA, West SM, Betts MR, et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV Infection. Immunity. 2004;21:793-803.
46. Dong T, Stewart-Jones G, Chen N, et al. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 2004;200:1547-1557.
47. Kalams SA, Johnson RP, Trocha AK, et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med. 1994;179:1261-1271.
48. + T lymphocyte population. J Immunol. 2001;166:4525-4533.
49. McCloskey TW, Haridas V, Pahwa R, Pahwa S. T cell receptor V beta repertoire of the antigen specific CD8 T lymphocyte subset of HIV infected children. AIDS. 2002;16:1459-1465.
50. Oxenius A, Gunthard HF, Hirschel B, et al. Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. Eur J Immunol. 2001;31:1115-1121.
51. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-763.
52. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001;410:106-111.
53. + T cells with an effector phenotype and control of viral replication. Lancet. 2004;363:863-866.